Furthermore, it is well known that patients with ADHD react favorably to therapy with Ritalin (methylphenidate) and Adderall (amphetamine), which target DAT (Dresel et al., 2000). Here, SLC6A3 is linked to attention deficit-hyperactivity disorder.